Nuklearmedizin-Nuclear Medicine

Papers
(The H4-Index of Nuklearmedizin-Nuclear Medicine is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging15
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer13
Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours12
Gemeinsame Handlungsempfehlung (S1-Leitlinie) von DGN, OGNMB und SGNM – Radiosynoviorthese – Stand: 9/2019 – AWMF-Registernummer: 031-02312
Improving quality of life in patients with metastatic prostate cancer following one cycle of 177Lu-PSMA-617 radioligand therapy: a pilot study9
Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany9
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma8
PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen: Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krank8
0.041024923324585